Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 205

1.

In the Limelight: August 2019.

Nath KA.

Mayo Clin Proc. 2019 Aug;94(8):1391-1394. doi: 10.1016/j.mayocp.2019.06.003. No abstract available.

PMID:
31378222
2.

In the Limelight: July 2019.

Nath KA.

Mayo Clin Proc. 2019 Jul;94(7):1125-1127. doi: 10.1016/j.mayocp.2019.05.020. No abstract available.

PMID:
31272558
3.

Heme Oxygenase-2 Protects Against Ischemic Acute Kidney Injury: The Influence of Age and Sex.

Nath KA, Garovic VD, Grande JP, Croatt AJ, Ackerman AW, Farrugia G, Katusic ZS, Belcher JD, Vercellotti GM.

Am J Physiol Renal Physiol. 2019 Jun 19. doi: 10.1152/ajprenal.00085.2019. [Epub ahead of print]

PMID:
31215802
4.

In the Limelight: June 2019.

Nath KA.

Mayo Clin Proc. 2019 Jun;94(6):929-932. doi: 10.1016/j.mayocp.2019.04.021. No abstract available.

PMID:
31171126
5.

In the Limelight: May 2019.

Nath KA.

Mayo Clin Proc. 2019 May;94(5):739-741. doi: 10.1016/j.mayocp.2019.03.021. No abstract available.

PMID:
31054598
6.

Corrigendum to "Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's disease" [EBioMedicine 2 (2015) 294-305].

Zhang L, Zhang S, Maezawa I, Trushin S, Minhas P, Pinto M, Jin LW, Prasain K, Nguyen TDT, Yamazaki Y, Kanekiyo T, Bu G, Gateno B, Chang KO, Nath KA, Nemutlu E, Dzeja P, Pang YP, Hua DH, Trushina E.

EBioMedicine. 2019 Apr;42:532. doi: 10.1016/j.ebiom.2019.03.062. Epub 2019 Apr 4. No abstract available.

7.

Global Village, International Travel, and Risk of Communicable Disease.

Sampathkumar P, Nath KA.

Mayo Clin Proc. 2019 Mar;94(3):383-384. doi: 10.1016/j.mayocp.2019.01.028. Epub 2019 Feb 21. No abstract available.

PMID:
30799051
8.

Early Onset Preeclampsia Is Associated With Glycocalyx Degradation and Reduced Microvascular Perfusion.

Weissgerber TL, Garcia-Valencia O, Milic NM, Codsi E, Cubro H, Nath MC, White WM, Nath KA, Garovic VD.

J Am Heart Assoc. 2019 Feb 19;8(4):e010647. doi: 10.1161/JAHA.118.010647.

9.

A Bicentennial, a Centennial, and Mayo Clinic Proceedings.

Nath KA.

Mayo Clin Proc. 2019 Jan;94(1):13-16. doi: 10.1016/j.mayocp.2018.11.017. No abstract available.

PMID:
30611440
10.

Current, Emerging, and Anticipated Therapies for Sickle Cell Disease.

Nath KA, Rajkumar SV.

Mayo Clin Proc. 2018 Dec;93(12):1703-1706. doi: 10.1016/j.mayocp.2018.10.010. No abstract available.

PMID:
30522590
11.

CKD Due to a Novel Mitochondrial DNA Mutation: A Case Report.

Fervenza FC, Gavrilova RH, Nasr SH, Irazabal MV, Nath KA.

Am J Kidney Dis. 2019 Feb;73(2):273-277. doi: 10.1053/j.ajkd.2018.06.032. Epub 2018 Oct 8.

PMID:
30309714
12.

The murine dialysis fistula model exhibits a senescence phenotype: pathobiological mechanisms and therapeutic potential.

Nath KA, O'Brien DR, Croatt AJ, Grande JP, Ackerman AW, Nath MC, Yamada S, Terzic A, Tchkonia T, Kirkland JL, Katusic ZS.

Am J Physiol Renal Physiol. 2018 Nov 1;315(5):F1493-F1499. doi: 10.1152/ajprenal.00308.2018. Epub 2018 Jul 18.

PMID:
30019935
13.

Ccl2 deficiency protects against chronic renal injury in murine renovascular hypertension.

Kashyap S, Osman M, Ferguson CM, Nath MC, Roy B, Lien KR, Nath KA, Garovic VD, Lerman LO, Grande JP.

Sci Rep. 2018 Jun 5;8(1):8598. doi: 10.1038/s41598-018-26870-y.

14.

Haptoglobin and hemopexin inhibit vaso-occlusion and inflammation in murine sickle cell disease: Role of heme oxygenase-1 induction.

Belcher JD, Chen C, Nguyen J, Abdulla F, Zhang P, Nguyen H, Nguyen P, Killeen T, Miescher SM, Brinkman N, Nath KA, Steer CJ, Vercellotti GM.

PLoS One. 2018 Apr 25;13(4):e0196455. doi: 10.1371/journal.pone.0196455. eCollection 2018.

15.

Managing the Hypoactive Sexual Desire Disorder in Women.

Garovic VD, Williams A, Nath KA.

Mayo Clin Proc. 2018 Apr;93(4):406-408. doi: 10.1016/j.mayocp.2018.02.015. Epub 2018 Mar 12. No abstract available.

PMID:
29545004
16.

Disease Progression and End-Stage Renal Disease in Diverse Glomerulopathies.

Nath KA, Fervenza FC.

Mayo Clin Proc. 2018 Feb;93(2):133-135. doi: 10.1016/j.mayocp.2017.12.018. Epub 2018 Jan 24. No abstract available.

PMID:
29395349
17.

Differentiating Primary, Genetic, and Secondary FSGS in Adults: A Clinicopathologic Approach.

De Vriese AS, Sethi S, Nath KA, Glassock RJ, Fervenza FC.

J Am Soc Nephrol. 2018 Mar;29(3):759-774. doi: 10.1681/ASN.2017090958. Epub 2018 Jan 10.

18.

Transitions and New Beginnings at Mayo Clinic Proceedings.

Nath KA.

Mayo Clin Proc. 2018 Jan;93(1):7-8. doi: 10.1016/j.mayocp.2017.11.011. No abstract available.

PMID:
29304924
19.

Renal Outcomes in Anticoagulated Patients With Atrial Fibrillation.

Yao X, Tangri N, Gersh BJ, Sangaralingham LR, Shah ND, Nath KA, Noseworthy PA.

J Am Coll Cardiol. 2017 Nov 28;70(21):2621-2632. doi: 10.1016/j.jacc.2017.09.1087.

20.

Role of TLR4 signaling in the nephrotoxicity of heme and heme proteins.

Nath KA, Belcher JD, Nath MC, Grande JP, Croatt AJ, Ackerman AW, Katusic ZS, Vercellotti GM.

Am J Physiol Renal Physiol. 2018 May 1;314(5):F906-F914. doi: 10.1152/ajprenal.00432.2017. Epub 2017 Oct 4.

21.

Challenges in Developing New Therapies for Vascular Access Dysfunction.

Nath KA, Allon M.

Clin J Am Soc Nephrol. 2017 Dec 7;12(12):2053-2055. doi: 10.2215/CJN.06650617. Epub 2017 Sep 11. No abstract available.

22.

Urinary Extracellular Vesicles of Podocyte Origin and Renal Injury in Preeclampsia.

Gilani SI, Anderson UD, Jayachandran M, Weissgerber TL, Zand L, White WM, Milic N, Suarez MLG, Vallapureddy RR, Nääv Å, Erlandsson L, Lieske JC, Grande JP, Nath KA, Hansson SR, Garovic VD.

J Am Soc Nephrol. 2017 Nov;28(11):3363-3372. doi: 10.1681/ASN.2016111202. Epub 2017 Jul 20.

23.

A monocyte-TNF-endothelial activation axis in sickle transgenic mice: Therapeutic benefit from TNF blockade.

Solovey A, Somani A, Belcher JD, Milbauer L, Vincent L, Pawlinski R, Nath KA, Kelm RJ Jr, Mackman N, O'Sullivan MG, Gupta K, Vercellotti GM, Hebbel RP.

Am J Hematol. 2017 Nov;92(11):1119-1130. doi: 10.1002/ajh.24856. Epub 2017 Jul 29.

24.

Affirming the Mission of Mayo Clinic Proceedings.

Nath KA.

Mayo Clin Proc. 2017 Jul;92(7):1015-1018. doi: 10.1016/j.mayocp.2017.05.024. No abstract available.

PMID:
28688463
25.

Endothelin-A Receptor Antagonism Retards the Progression of Murine Sickle Cell Nephropathy.

Nath KA, Katusic ZS.

J Am Soc Nephrol. 2017 Aug;28(8):2253-2255. doi: 10.1681/ASN.2017030320. Epub 2017 Apr 25. No abstract available.

26.

Transition of Editor-in-Chief Duties at Mayo Clinic Proceedings.

Lanier WL, Nath KA.

Mayo Clin Proc. 2017 Apr;92(4):488-489. doi: 10.1016/j.mayocp.2017.03.001. No abstract available.

PMID:
28385195
27.

Long-term cardiovascular changes following creation of arteriovenous fistula in patients with end stage renal disease.

Reddy YNV, Obokata M, Dean PG, Melenovsky V, Nath KA, Borlaug BA.

Eur Heart J. 2017 Jun 21;38(24):1913-1923. doi: 10.1093/eurheartj/ehx045.

PMID:
28329100
28.

A proposal for standardized grading of chronic changes in native kidney biopsy specimens.

Sethi S, D'Agati VD, Nast CC, Fogo AB, De Vriese AS, Markowitz GS, Glassock RJ, Fervenza FC, Seshan SV, Rule A, Racusen LC, Radhakrishnan J, Winearls CG, Appel GB, Bajema IM, Chang A, Colvin RB, Cook HT, Hariharan S, Herrera Hernandez LP, Kambham N, Mengel M, Nath KA, Rennke HG, Ronco P, Rovin BH, Haas M.

Kidney Int. 2017 Apr;91(4):787-789. doi: 10.1016/j.kint.2017.01.002.

PMID:
28314581
29.

Vascular Access for Hemodialysis and Value-Based Purchasing for ESRD.

Mehrotra R, Cheung AK, Meyer T, Nath KA.

J Am Soc Nephrol. 2017 Feb;28(2):395-397. doi: 10.1681/ASN.2016070769. Epub 2016 Oct 6. No abstract available.

30.

A Randomized, Controlled Trial of Rituximab in IgA Nephropathy with Proteinuria and Renal Dysfunction.

Lafayette RA, Canetta PA, Rovin BH, Appel GB, Novak J, Nath KA, Sethi S, Tumlin JA, Mehta K, Hogan M, Erickson S, Julian BA, Leung N, Enders FT, Brown R, Knoppova B, Hall S, Fervenza FC.

J Am Soc Nephrol. 2017 Apr;28(4):1306-1313. doi: 10.1681/ASN.2016060640. Epub 2016 Nov 7.

31.

A Proposal for a Serology-Based Approach to Membranous Nephropathy.

De Vriese AS, Glassock RJ, Nath KA, Sethi S, Fervenza FC.

J Am Soc Nephrol. 2017 Feb;28(2):421-430. doi: 10.1681/ASN.2016070776. Epub 2016 Oct 24. Review.

32.

Predicting the Functionality and Form of a Dialysis Fistula.

Nath KA, Katusic ZS.

J Am Soc Nephrol. 2016 Dec;27(12):3508-3510. Epub 2016 Aug 4. No abstract available.

33.

Development of renal atrophy in murine 2 kidney 1 clip hypertension is strain independent.

Kashyap S, Boyilla R, Zaia PJ, Ghossan R, Nath KA, Textor SC, Lerman LO, Grande JP.

Res Vet Sci. 2016 Aug;107:171-177. doi: 10.1016/j.rvsc.2016.06.002. Epub 2016 Jun 8.

34.

Celebrating the ASN at 50.

Harris RC, Ibrahim T, Nath KA.

J Am Soc Nephrol. 2016 Jun;27(6):1575-6. doi: 10.1681/ASN.2016040445. Epub 2016 May 3. No abstract available.

35.

Control of Oxidative Stress and Inflammation in Sickle Cell Disease with the Nrf2 Activator Dimethyl Fumarate.

Belcher JD, Chen C, Nguyen J, Zhang P, Abdulla F, Nguyen P, Killeen T, Xu P, O'Sullivan G, Nath KA, Vercellotti GM.

Antioxid Redox Signal. 2017 May 10;26(14):748-762. doi: 10.1089/ars.2015.6571. Epub 2016 Mar 30.

36.

A new model of an arteriovenous fistula in chronic kidney disease in the mouse: beneficial effects of upregulated heme oxygenase-1.

Kang L, Grande JP, Hillestad ML, Croatt AJ, Barry MA, Katusic ZS, Nath KA.

Am J Physiol Renal Physiol. 2016 Mar 15;310(6):F466-76. doi: 10.1152/ajprenal.00288.2015. Epub 2015 Dec 16.

37.

Blockade of CCR2 reduces macrophage influx and development of chronic renal damage in murine renovascular hypertension.

Kashyap S, Warner GM, Hartono SP, Boyilla R, Knudsen BE, Zubair AS, Lien K, Nath KA, Textor SC, Lerman LO, Grande JP.

Am J Physiol Renal Physiol. 2016 Mar 1;310(5):F372-84. doi: 10.1152/ajprenal.00131.2015. Epub 2015 Dec 9.

38.

Mayo Clinic/Renal Pathology Society Consensus Report on Pathologic Classification, Diagnosis, and Reporting of GN.

Sethi S, Haas M, Markowitz GS, D'Agati VD, Rennke HG, Jennette JC, Bajema IM, Alpers CE, Chang A, Cornell LD, Cosio FG, Fogo AB, Glassock RJ, Hariharan S, Kambham N, Lager DJ, Leung N, Mengel M, Nath KA, Roberts IS, Rovin BH, Seshan SV, Smith RJ, Walker PD, Winearls CG, Appel GB, Alexander MP, Cattran DC, Casado CA, Cook HT, De Vriese AS, Radhakrishnan J, Racusen LC, Ronco P, Fervenza FC.

J Am Soc Nephrol. 2016 May;27(5):1278-87. doi: 10.1681/ASN.2015060612. Epub 2015 Nov 13.

39.

Models of Human AKI: Resemblance, Reproducibility, and Return on Investment.

Nath KA.

J Am Soc Nephrol. 2015 Dec;26(12):2891-3. doi: 10.1681/ASN.2015101109. Epub 2015 Nov 4. No abstract available.

40.

Dialysis Vascular Access Intervention and the Search for Biomarkers.

Nath KA.

J Am Soc Nephrol. 2016 Apr;27(4):970-2. doi: 10.1681/ASN.2015090982. Epub 2015 Oct 9. No abstract available.

41.

Kidney Disease Caused by Dysregulation of the Complement Alternative Pathway: An Etiologic Approach.

De Vriese AS, Sethi S, Van Praet J, Nath KA, Fervenza FC.

J Am Soc Nephrol. 2015 Dec;26(12):2917-29. doi: 10.1681/ASN.2015020184. Epub 2015 Jul 16. Review.

42.

Modulation of mitochondrial complex I activity averts cognitive decline in multiple animal models of familial Alzheimer's Disease.

Zhang L, Zhang S, Maezawa I, Trushin S, Minhas P, Pinto M, Jin LW, Prasain K, Nguyen TD, Yamazaki Y, Kanekiyo T, Bu G, Gateno B, Chang KO, Nath KA, Nemutlu E, Dzeja P, Pang YP, Hua DH, Trushina E.

EBioMedicine. 2015 Apr 1;2(4):294-305. Erratum in: EBioMedicine. 2019 Apr;42:532.

43.

JASN's Silver Jubilee.

Nath KA, Neilson EG, Couser WG, Tisher CC, Grantham JJ.

J Am Soc Nephrol. 2015 Jul;26(7):1477-8. doi: 10.1681/ASN.2015050537. Epub 2015 Jun 4. No abstract available.

44.

Induction and functional significance of the heme oxygenase system in pathological shear stress in vivo.

Kang L, Hillestad ML, Grande JP, Croatt AJ, Barry MA, Farrugia G, Katusic ZS, Nath KA.

Am J Physiol Heart Circ Physiol. 2015 Jun 1;308(11):H1402-13. doi: 10.1152/ajpheart.00882.2014. Epub 2015 Mar 27.

45.

Sickle cell disease: renal manifestations and mechanisms.

Nath KA, Hebbel RP.

Nat Rev Nephrol. 2015 Mar;11(3):161-71. doi: 10.1038/nrneph.2015.8. Epub 2015 Feb 10. Review.

46.

H-ferritin ferroxidase induces cytoprotective pathways and inhibits microvascular stasis in transgenic sickle mice.

Vercellotti GM, Khan FB, Nguyen J, Chen C, Bruzzone CM, Bechtel H, Brown G, Nath KA, Steer CJ, Hebbel RP, Belcher JD.

Front Pharmacol. 2014 Apr 17;5:79. doi: 10.3389/fphar.2014.00079. eCollection 2014.

47.

Heme triggers TLR4 signaling leading to endothelial cell activation and vaso-occlusion in murine sickle cell disease.

Belcher JD, Chen C, Nguyen J, Milbauer L, Abdulla F, Alayash AI, Smith A, Nath KA, Hebbel RP, Vercellotti GM.

Blood. 2014 Jan 16;123(3):377-90. doi: 10.1182/blood-2013-04-495887. Epub 2013 Nov 25.

48.

Heme oxygenase-1 and acute kidney injury.

Nath KA.

Curr Opin Nephrol Hypertens. 2014 Jan;23(1):17-24. doi: 10.1097/01.mnh.0000437613.88158.d3. Review.

49.

Redox signaling is an early event in the pathogenesis of renovascular hypertension.

Hartono SP, Knudsen BE, Zubair AS, Nath KA, Textor SJ, Lerman LO, Grande JP.

Int J Mol Sci. 2013 Sep 10;14(9):18640-56. doi: 10.3390/ijms140918640.

50.

AKI: a path forward.

Bonventre JV, Basile D, Liu KD, McKay D, Molitoris BA, Nath KA, Nickolas TL, Okusa MD, Palevsky PM, Schnellmann R, Rys-Sikora K, Kimmel PL, Star RA; Kidney Research National Dialogue (KRND).

Clin J Am Soc Nephrol. 2013 Sep;8(9):1606-8. doi: 10.2215/CJN.06040613. Epub 2013 Jul 18.

Supplemental Content

Support Center